Revolve Group RVLV 深 沪
等待开盘 09-18 09:30:00 美东时间
23.90
+0.070
+0.29%
华盛通- 最 高24.52
- 今 开23.83
- 成交量 135.24万股
- 最 低 23.54
- 昨 收 23.83
- 总市值 17.04亿
- 52周最高 39.5778
- 市盈率 静 34.57
- 换手率 1.90%
- 52周最低 16.80
- 委 比 36.71%
- 总股本 7128.91万
- 历史最高 89.60
- 量 比 1.18
- 振 幅 4.11%
- 历史最低 7.17
- 每 手 1
- 风险率 5.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Armani's Fashionable Exit: Can Heirs Turn Couture Into Cash For Investors?
Armani's heirs considering public sale of fashion giant could signal luxury market trends, impacting TPR, CPRI, LVMH, Kering, Farfetch and Revolve.
09-16 02:21
Revolver Resources Secures A$1.35M for Dianne Copper Mine Advancement
An announcement from Revolver Resources Holdings Ltd ( ($AU:RRR) ) is now avail...
09-15 09:09
LENDINGTREE ANNOUNCES CLOSING OF $475 MILLION CREDIT FACILITY
New Financing Reduces Interest Expense, Removes Cumbersome Covenants, and Increases Operating Flexibility CHARLOTTE, N.C., Aug. 22, 2025 /PRNewswire/ -- LendingTree, Inc. (NASDAQ: TREE), the...
08-22 20:32
NeoTerrex Completes Phase I Exploration on Revolver REE Project
NeoTerrex Minerals Inc ( ($TSE:NTX) ) has issued an announcement. NeoTerrex Min...
08-21 22:09
NIQ Global Intelligence Reported Q2 Revenue Of $1.04B Vs $985.8M YoY, Adj EPS Loss Of $(0.02) Vs $(0.38) YoY
Second Quarter 2025 & Recent HighlightsFinancial:Total revenue grew 5.6% year-over-year to $1,040.8 million. Organic constant currency revenue grew 5.7%, led by EMEA and Americas, which grew 8.1% and 5.4%,
08-14 19:18
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
Revolve Group shares are trading lower. The company reported Q2 financial results.
Revolve Group shares are trading lower. The company reported Q2 financial resul...
08-07 00:55
美股大行评级 | 潜在涨幅345.51%！BTIG上调Syndax Pharmaceuticals目标价至56美元，维持"买入"评级
今日重点评级关注：BTIG：维持Syndax Pharmaceuticals"买入"评级，目标价从43美元升至56美元；花旗：维持Syndax Pharmaceuticals"买入"评级，目标价从46美元升至51美元
08-06 09:30
Roth Capital Maintains Buy on Revolve Gr, Raises Price Target to $24
Roth Capital analyst Matt Koranda maintains Revolve Gr (NYSE:RVLV) with a Buy and raises the price target from $19 to $24.
08-06 01:18
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
